Shares of Biotest Aktiengesellschaft (ETR:BIO – Get Free Report) fell 1% during mid-day trading on Wednesday . The stock traded as low as €41.00 ($43.16) and last traded at €41.00 ($43.16). 508 shares were traded during trading, a decline of 74% from the average session volume of 1,927 shares. The stock had previously closed at €41.40 ($43.58).
Biotest Aktiengesellschaft Trading Up 0.5 %
The company has a debt-to-equity ratio of 116.50, a current ratio of 2.45 and a quick ratio of 1.66. The company has a market cap of $823.26 million, a price-to-earnings ratio of 10.02 and a beta of 0.24. The business’s fifty day moving average price is €41.55 and its 200 day moving average price is €41.63.
Biotest Aktiengesellschaft Company Profile
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Featured Articles
- Five stocks we like better than Biotest Aktiengesellschaft
- How to Read Stock Charts for Beginners
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- What is the Shanghai Stock Exchange Composite Index?
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
